{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-032469","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.342892+00:00","generated_at":"2026-05-31T09:00:17.378119+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Propanc Biopharma issues $33K convertible promissory note to GS Capital at 8% interest","bullets":["Company entered securities purchase agreement with GS Capital Partners on Aug 9, 2024 for $33,000 principal note at $30,000 purchase price.","Note matures Feb 2, 2025, bears 8% interest, convertible at $0.0017/share initially, adjustable to $0.001 if stock trades below $0.0014 for 5 days.","Company can prepay at 110% within 60 days, escalating to 125% after 120 days; no prepayment after 180 days.","Proceeds used for working capital; note issued under Section 4(a)(2) and Rule 506 of Regulation D.","Default events include failure to maintain OTC Markets listing, breach of covenants; interest rises to 24% on default."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-032469","json":"https://secwatch.observer/filing/0001493152-24-032469.json","markdown":"https://secwatch.observer/filing/0001493152-24-032469.md","text":"https://secwatch.observer/filing/0001493152-24-032469.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224032469/0001493152-24-032469-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224032469/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:00:17.378119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}